Sign In
Buy MEDIF
$0.0539
-0.0024 (-4.33%)
At Close: Jun 03, 2026
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
08:00am, Thursday, 13'th Nov 2025
Q3 2025 Revenue of $11.4 Million, an Increase of 17% over Q3 2024 83% Growth in Year-Over-Year Revenue for International Medical Cannabis International Medical sales now 56% of Total Revenue Increase
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
06:00pm, Monday, 10'th Nov 2025
TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in preci
/U P D A T E -- MediPharm Labs Corp./
04:30pm, Friday, 07'th Nov 2025
In the news release, MediPharm Labs Raises Concerns About Poorly Qualified Dissident Nominees, issued 15-May-2025 by MediPharm Labs Corp. over PR Newswire, please be advised that updates have been mad
/U P D A T E -- MediPharm Labs Corp./
04:19pm, Friday, 07'th Nov 2025
In the news release, MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders, issued 13-May-2025 by MediPharm Labs Corp. over PR Newswire, please be advised that updates have been
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
07:30am, Thursday, 14'th Aug 2025
Q2 Revenue of $11.8 Million, an Increase of 14% over Q2 2024 50% Growth in Revenue for International Medical Cannabis International Medical sales now 57% of Total Revenue Cash Balance of $10.4 Millio
MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States
07:30am, Wednesday, 13'th Aug 2025
MediPharm Labs holds unique US Food and Drug Administration (FDA) site registration in relation to the manufacturing and release of pharmaceutical cannabis products. MediPharm is the only US FDA Au
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
07:38am, Monday, 11'th Aug 2025
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in preci
MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
07:00am, Thursday, 24'th Jul 2025
TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specializing in precisi
MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
10:27am, Tuesday, 17'th Jun 2025
TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based ca
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
01:22pm, Monday, 16'th Jun 2025
TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based ca
Apollo Capital Wins Proxy Contest at MediPharm Labs
11:15am, Monday, 16'th Jun 2025
MediPharm Labs' Board's Material and Unprecedented Breaches of Securities Laws Are Part of Their Undoing
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
08:59am, Friday, 13'th Jun 2025
TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based ca
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
07:00pm, Wednesday, 11'th Jun 2025
TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm,” the “Company,” “we” or “us”), a pharmaceutical company specialized i
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
05:49pm, Wednesday, 11'th Jun 2025
TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based ca
TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- Apollo Technology Capital Corporation (“Apollo Capital”), which together with its affiliates and associates collectively is one of the largest shareholde
